Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (411-420 of 497) with videos related to

Pageof 50
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
The Journal of Clinical Investigation|October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Molecular Genetics|July 6, 2016
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer riskJennifer B Permuth, Ailith Pirie, Y Ann Chen, et al.
Cell|June 4, 2026
Plasma signals of lung tumor promotion for molecular cancer preventionTej Pandya, Maria Zagorulya, Michelle M Leung, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Nature Genetics|August 4, 2009
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Honglin Song, Susan J Ramus, Jonathan Tyrer, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Pageof 50

Showing results (411-420 of 497) with videos related to

Sort By:
Pageof 50
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
The Journal of Clinical Investigation|October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Human Molecular Genetics|July 6, 2016
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer riskJennifer B Permuth, Ailith Pirie, Y Ann Chen, et al.
Cell|June 4, 2026
Plasma signals of lung tumor promotion for molecular cancer preventionTej Pandya, Maria Zagorulya, Michelle M Leung, et al.
British Journal of Cancer|January 20, 2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility lociSiddhartha P Kar, Emily Adler, Jonathan Tyrer, et al.
Nature Genetics|August 4, 2009
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2Honglin Song, Susan J Ramus, Jonathan Tyrer, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Pageof 50